N-(3,4-dimethoxyphenyl)-N-(3-pyridylmethyl)-3-aminobenzoic acid | 651023-21-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-(3,4-dimethoxyphenyl)-N-(3-pyridylmethyl)-3-aminobenzoic acid
• 英文别名: Benzoic acid, 3-[(3,4-dimethoxyphenyl)(3-pyridinylmethyl)amino]-；3-[3,4-dimethoxy-N-(pyridin-3-ylmethyl)anilino]benzoic acid
• CAS: 651023-21-1
• 化学式: C₂₁H₂₀N₂O₄
• 分子量: 364.401
• InChiKey: KRPPZQRYUHTBRL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  27
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  71.9
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• [EN] PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS<br/>[FR] INHIBITEURS DE PHOSPHODIESTERASE 4 COMPRENANT DES ANALOGUES DE DIPHENYLAMINE ET D'ANILINE N-SUBSTITUES
  申请人：MEMORY PHARM CORP

  公开号：WO2004009552A1

  公开（公告）日：2004-01-29

  PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula (I): wherein R1, R2 R 3 and R4 are as defined herein.

  PDE4抑制作用是通过新型化合物实现的，例如N-取代苯胺和二苯胺类似物。本发明的化合物为公式(I)：其中R1，R2，R3和R4如本文所述定义。
• Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
  申请人：Schumacher A. Richard

  公开号：US20050119225A1

  公开（公告）日：2005-06-02

  PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R 1 , R 2 , R 3 and R 4 are as defined herein.

  PDE4抑制是通过新型化合物实现的，例如，N-取代苯胺和二苯胺类似物。本发明的化合物属于公式I：其中R1，R2，R3和R4如本文所定义。
• PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS
  申请人：SCHUMACHER Richard A.

  公开号：US20090048255A1

  公开（公告）日：2009-02-19

  PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R 1 , R 2 , R 3 and R 4 are as defined herein.

  PDE4抑制是通过新型化合物实现的，例如N-取代苯胺和二苯胺类似物。本发明的化合物属于I式：其中R1、R2、R3和R4的定义如本文所述。
• US7405230B2
  申请人：——

  公开号：US7405230B2

  公开（公告）日：2008-07-29
• [EN] COMBINATIONS OF PDE4 INHIBITORS AND ANTIPSYCHOTICS FOR THE TREATMENT OF PSYCHOTIC DISORDERS<br/>[FR] COMBINAISONS D'INHIBITEURS DE PDE4 ET D'ANTIPSYCHOTIQUES POUR LE TRAITEMENT DE TROUBLES PSYCHOTIQUES
  申请人：MEMORY PHARM CORP

  公开号：WO2009067607A2

  公开（公告）日：2009-05-28

  The invention relates to methods and compositions for treating a psychotic disorder or condition, associated with cognitive impairment. The pharmaceutical composition comprises: (a) an amount of an antipsychotic agent and (b) an amount of a PDE4 inhibitor compound, wherein the amounts of (a) and (b) are together effective in treating the cognitive impairment or psychotic disorder such as schizophrenia. The method of treatment comprises administering to a patient (a) an amount of a antipsychotic agent and (b) an amount of a PDE4 inhibitor compound, wherein the amounts of (a) and (b) are together effective in treating the psychotic disorder such as schizophrenia.